Pioneering diagnostics
E.g., 29/01/2015
E.g., 29/01/2015

bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury

22 January, 2015

Marcy l’Etoile, (France) - San Diego, California (United States) - January 22, 2015 - bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and...

Business Review for the Three Months and Full Year Ended December 31, 2014

22 January, 2015

Sales: solid growth, lifted sharply by BioFire

  • Revenue: €1,698 million, up a reported 7%
  • Up 8.7%, including BioFire and at constant exchange rates
  • Up 3.8% at constant exchange rates and scope of consolidation, in line with...

Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency

bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision

09 January, 2015

Marcy l’Etoile (France) - Brescia (Italy), January 9, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce that they have signed a strategic...

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

18 November, 2014

Marcy l’Etoile, FranceSan Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an...

BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test

27 October, 2014

Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for its commercial FilmArray...

Business Review for the Nine Months Ended September 30, 2014

22 October, 2014

Solid growth in nine-month sales:

  • Up 7.4%, including BioFire and at constant exchange rates
  • Up 3.5% at constant exchange rates and scope of consolidation, in line with the full-year target

The Americas: a...

bioMérieux inaugurates a new multidisciplinary R&D center for infectious disease diagnostics

Marcy l’Etoile, October 10, 2014 – A new bioMérieux R&D center was inaugurated at the company’s La Balme-Les-Grottes site (Isère, southeastern France) by Alain Mérieux, Chairman of Institut Mérieux, Jean-Luc Bélingard, Chairman of bioMérieux, and Alexandre Mérieux, Chief Executive Officer of bioMérieux. Geneviève Fioraso, French Secretary of State for Higher Education and Research, attended the ceremony.

10 October, 2014

The R&D Center at La Balme-Les-Grottes is specialized in the development of new diagnostic solutions in microbiology: high medical value tests for improved patient care and fully automated solutions to reduce time to results and enhance the efficiency of laboratory workflows.

...

bioMérieux launches chromID® Salmonella Elite, the new generation of culture media for earlier detection of Salmonella strains in clinical fecal samples

18 September, 2014

Marcy l'Étoile, France – September 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of chromID® Salmonella Elite, a new selective chromogenic culture medium for the isolation and rapid identification of...

bioMérieux - First-Half 2014 Results

03 September, 2014

Solid growth in first-half sales

  • Up 7.9%, including BioFire and at constant exchange rates
  • Up 4.2% at constant exchange rates and scope of consolidation

2014 financial objectives maintained

...

bioMérieux VIRTUO™, the new generation of blood culture system, is CE-marked

VIRTUO™ is the next dimension of blood culture microbial detection

23 July, 2014

Marcy l'Etoile, France, July 23, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIRTUO™, the new generation of BacT/ALERT®, has been CE-marked. This uniquely innovative automated blood culture microbial...